Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUltrasis Plc Regulatory News (ULT)

  • There is currently no data for ULT

New contract

26 Apr 2010 07:01

RNS Number : 7378K
Ultrasis PLC
26 April 2010
 

Ultrasis plc

 

Ultrasis' "Beating the Blues" breaks new ground

with major UK health provider

 

Ultrasis plc, the provider of interactive healthcare and related services, is pleased to announce a five-year exclusive contract with General Healthcare Group (GHG), the UK's largest independent provider of private healthcare, to deliver "Beating the Blues" (BTB) within the UK private healthcare market.

 

The service, to be offered primarily by GHG's principal subsidiary company, BMI Healthcare, will use BTB, the computer delivered treatment program that uses established techniques in Cognitive Behavioural Therapy (CBT) to treat depression and anxiety.

 

BMI will deliver immediate access to BTB over the internet with additional telephone support, or alongside clinician delivered services. It will initially be made available:

 

·;  Direct to patients and consumers through the BMI Healthcare website.

·;  By direct referral from a range of BMI clinical staff.

·;  As part of the wider BMI provision of healthcare services.

 

Nigel Brabbins, Ultrasis Chief Executive, said:

 

"This strategic partnership will significantly enhance our reach within the private sector and opens new therapeutic territory to BTB. BMI is the leading independent healthcare provider in the UK and we are delighted that they have chosen to work with Ultrasis to make BTB a core part of their emotional and mental health support for patients. We expect to see BMI patients receiving the service during June 2010."

 

He added: "Cognitive Behavioural Therapy is now recognised as a treatment option for co-morbidity depression experienced in association with many primary illnesses. We look forward to demonstrating the increased benefits of using BTB to help people deal with any underlying or primary emotional problems.

 

"The two recent NICE Guidelines regarding treatment of depression have broadened the application of BTB to co-morbidity and this partnership with BMI will provide us with the platform to significantly scale up delivery."

 

Mark Beadle, Managing Director of Mental Healthcare Services at GHG, said:

 

"We are delighted to be working with Ultrasis to improve patient access to psychological services within BMI hospitals. Evidence shows that for many patients their outcomes will be improved by the treatment of anxiety or depression alongside the treatment of their underlying physical condition. BTB has already demonstrated excellent clinical outcomes and represents an extremely cost effective treatment option for our patients.

"We also look forward to working more widely with Ultrasis to improve the availability and accessibility of Beating the Blues to a wider market."

 

Ends

 

Notes to editors

1. Beating the Blues is an evidence based computer delivered treatment program that uses established techniques in Cognitive Behavioural Therapy to treat depression and anxiety cost effectively. Computer-aided Cognitive Behavioural Therapy ("CCBT") is now recommended by NICE as a treatment option for people with mild and moderate depression who have a chronic physical illness as well as for those who are in good physical health. Since the NICE Health Technology of CCBT published in 2006 Beating the Blues has been the leading programme used within the NHS.

 

2. CCBT was recently highlighted by NICE as capable of delivering £250m of the £600m potential savings presented in its recent Cost Saving Guidance to the NHS.

 

3. The recent NICE Guidelines on treating depression in adults with chronic physical health problems highlights that depression is two to three times more common in this population than in people with good physical health. Treating the depression can help alleviate the pain and distress associated with the physical illness and has been proven to have a positive effect on clinical outcomes.

 

3 General Healthcare Group is the UK's largest independent provider of private healthcare. Its major subsidiary is BMI Healthcare, which has more than 70 hospitals and clinics across the country. More than 7,000 consultants choose to practice at BMI hospitals, which collectively handle over 250,000 inpatient and one million outpatient visits each year. BMI focuses on clinical excellence, quality of service and efficiency, and has a deserved reputation in the independent health care sector for consistent achievement of these values. For more information, please visit www.bmihealthcare.co.uk.

Other key facts about BMI:

·; 99% patient satisfaction rating of good or better*

·; 115 specialities and services

·; 89% of UK adults live less than an hour from a BMI hospital

·; 9,200 employees

·; 2,900 beds

·; 1.5 million website visits per year**

* Source: Patient satisfaction survey, Howard Warwick & Associates, Jan-Sept 2009 ** 1,478,000 unique visits to BMI Healthcare's website in 2009

 

For more information:

 

Nigel Brabbins Ultrasis CEO E-Mail: ultrasis@ultrasis.com Telephone: +44 (0) 20 7566 3900 Fax: +44 (0) 20 7253 5313

 

Geoff Nash FinnCap Nominated Adviser and Joint Broker Telephone: +44 (0) 20 7600 1658

 

John Webb Marshall Securities Joint Broker Telephone: +44 (0) 207 490 3788

 

Karen White/Sarah Rice

JBP Public Relations (UK media enquiries)

0117 907 3400

E-Mail: Karen.white@jbp.co.uk; sarah.rice@jbp.co.uk

 

GHG/BMI Press Contact:

 

Linda Apeles

0207 009 4544

Linda.Apeles@ghg.co.uk

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTLLFIRSTIVFII
Date   Source Headline
19th Sep 20117:00 amRNSMajor new initiative in the Netherlands
12th Sep 20117:00 amRNSBeating the Blues to be used in US Army Research
10th May 20113:00 pmRNSBlocklisting Interim Review
7th Mar 20117:00 amRNSHalf Yearly Report
10th Feb 201111:31 amRNSHolding(s) in Company
31st Jan 20117:00 amRNSResult of AGM
27th Jan 20117:00 amRNSAnnouncement of new partnership agreement
10th Jan 20117:00 amRNSNew contract
23rd Dec 20109:00 amRNSAnnual Report and Accounts Posting
20th Dec 20107:00 amRNSChange of Adviser
30th Nov 20107:00 amRNSFinal Results
9th Nov 201010:29 amRNSBlock Admission of Shares
3rd Nov 20107:00 amRNSStrategic Partnership
15th Sep 20107:00 amRNSBreakthrough in New Zealand
3rd Sep 20108:55 amRNSHolding(s) in Company
26th Aug 20107:00 amRNSNew contract
30th Jun 201010:34 amRNSChange of Registered Office and name of Adviser
26th Apr 20107:01 amRNSNew contract
26th Apr 20107:00 amRNSHalf Yearly Report
1st Apr 20107:00 amRNSInsomnia Research Project
30th Mar 20107:00 amRNSRe reimbursement for Beating the Blues
16th Mar 20107:00 amRNSNew contract
11th Feb 20107:00 amRNSStrategic collaboration
9th Feb 20107:00 amRNSNew Territory
28th Jan 20105:22 pmRNSResult of AGM
26th Jan 20107:00 amRNSEU research grant in ICT applied to mental health
21st Dec 20092:00 pmRNSPosting of Annual Report and Accounts
4th Nov 20097:01 amRNSDirectorate Change
4th Nov 20097:00 amRNSFinal Results
28th Oct 20092:08 pmRNSCorrection re NICE Guidance
28th Oct 200912:09 pmRNSNICE Guidance
8th Oct 20091:12 pmRNSRoll-out of product in the Netherlands
31st Jul 20097:00 amRNSIssue of Equity
22nd Jul 20098:25 amRNSContract renewed
11th May 200911:06 amRNSHolding(s) in Company
23rd Mar 20091:46 pmRNSHolding(s) in Company
11th Mar 20097:00 amRNSContract Win
3rd Mar 200912:48 pmRNSHolding(s) in Company
27th Feb 20099:19 amRNSResult of AGM
23rd Feb 20091:00 pmRNSInterim Results
20th Feb 200910:03 amRNSContract win
11th Feb 20093:00 pmRNSDoc re. AGM resolutions
27th Jan 20092:51 pmRNSTotal Voting Rights
27th Jan 20092:45 pmRNSAnnual Report and Accounts
18th Dec 20081:24 pmRNSAcquisition
4th Dec 20082:51 pmRNSResult of EGM
3rd Dec 20087:00 amRNSSpeech by Alan Johnson
26th Nov 20087:00 amRNSContract Win
25th Nov 20087:00 amRNSExtension of contract
17th Nov 20088:37 amRNSCorrection re new contract

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.